诺维利亚荣获2026年药物开发创新领域激烈外包奖

Recognition Highlights Novellia's Patient-Authorized RWD Platform as a Force in Advancing Biopharma Research

诺维利娅的患者授权真实世界数据平台被评为推动生物制药研究的重要力量

NEW YORK

纽约

,

，

April 14, 2026

2026年4月14日

/PRNewswire/ --

/PRNewswire/ --

Novellia

诺维利亚

, the only real-world data company built entirely on information patients choose to contribute to medical research, today announced it has won the 2026 Fierce Outsourcing Award for Innovation in Drug Development. Presented by Fierce Pharma, one of the most widely read trade publications in the life sciences industry, the award recognizes the platforms and partnerships delivering the greatest advances in how drugs are discovered, developed, and brought to patients..

，唯一一家完全基于患者选择贡献给医学研究的信息构建的现实世界数据公司，今天宣布其荣获2026年《猛药》外包创新奖——药物开发类。该奖项由生命科学行业读者最广泛的贸易出版物之一《猛药》颁发，旨在表彰在药物发现、开发和交付患者过程中取得最大进步的平台和合作伙伴关系。

Novellia was selected over a finalist field that included organizations representing some of the most respected names in clinical research and drug development outsourcing.

诺维拉是从一个包括一些在临床研究和药物开发外包领域最受尊敬的机构在内的决赛名单中被选中的。

Pharmaceutical researchers have long depended on real-world data to understand how treatments perform outside clinical trials. But today's data ecosystem is still dominated by third-party brokers stitching together partial records from insurance claims and hospital systems, without the patient ever having a say.

制药业研究人员长期以来一直依赖真实世界的数据来了解治疗在临床试验之外的表现。但如今的数据生态系统仍由第三方经纪人主导，他们将来自保险索赔和医院系统的部分记录拼接在一起，而患者却始终没有发言权。

The result is a system that costs the industry over $50 billion annually and still leaves out the most important source of truth: the patient..

结果是一个每年花费行业超过 500 亿美元的系统，却仍然遗漏了最重要的真相来源：患者。

Novellia was built to solve that. Its AI-powered platform gives patients a free tool to find and unify 20+ years of medical records in seconds, then puts that deidentified, anonymized data in the hands of the world's leading life science companies to fuel new cures and treatments.

诺维利亚就是为了应对这一挑战而建立的。其人工智能驱动的平台为患者提供了一个免费工具，可以在几秒钟内查找并整合20多年的医疗记录，然后将这些去标识化、匿名化的数据交到全球领先的生命科学公司手中，以推动新疗法和治疗手段的研发。

'The breakthroughs coming in medicine will be built on patient trust,' says Shashi Shankar, Co-founder and CEO of Novellia. 'That is the resource the industry was missing, and it was missing because no one went to ask for it. Novellia built a system for the people carrying the heaviest diagnoses, cancer, chronic, and rare diseases.

“医学领域的突破将建立在患者信任的基础上，”诺维利亚公司联合创始人兼首席执行官沙希·尚卡尔表示。“这是该行业一直缺失的资源，而缺失的原因是没有人去争取。诺维利亚为那些承受最沉重诊断的人——癌症、慢性病和罕见病患者——建立了一套系统。”

That relationship means researchers can finally see the full picture of how disease unfolds across real lives over real years. We are proud of this recognition. We are more proud of what it is going to make possible.'.

这种关系意味着研究人员终于能够全面了解疾病在真实生活中随时间发展的全貌。我们为这一认可感到自豪，更为它将带来的可能性感到骄傲。

Within 30 seconds, Novellia helps patients with serious and complex conditions unify fragmented records from disparate hospital systems, doctors' offices, and labs across the U.S., to get the clearest, most complete view of their own care journey. The platform analyzes those records for meaningful patterns and turns them into anonymized, harmonized datasets shared with research partners.

在30秒内，Novellia帮助患有严重和复杂疾病的患者整合来自美国各地不同医院系统、医生办公室和实验室的碎片化记录，以获得最清晰、最完整的个人护理历程视图。该平台分析这些记录中的有意义模式，并将其转化为匿名且统一的数据集，与研究合作伙伴共享。

Its customers include several of the top 10 pharmaceutical companies..

其客户包括几家排名前十的制药公司。

Winners of the Fierce Outsourcing awards will be celebrated during Fierce Biotech Week on Wednesday, May 13.

“激烈外包”奖的获奖者将于5月13日星期三在“激烈生物技术周”期间庆祝。

About Novellia

关于Novellia

Novellia, Inc. is a patient data company that helps people find and unify over 20 years of health data in seconds so they can get better care, while accelerating medical breakthroughs. Named one of 10 start-up companies to watch by Digital Health New York, Novellia is the only real-world data company built entirely on information patients volunteer to share with pharmaceutical companies.

诺维利亚公司是一家患者数据公司，帮助人们在数秒内查找和整合超过20年的健康数据，从而获得更好的医疗护理，同时加速医学突破。诺维利亚被《数字健康纽约》评为值得关注的十家初创公司之一，是唯一一家完全基于患者自愿与制药公司分享信息的真实世界数据公司。

Novellia is backed by peer-reviewed research presented at medical congresses, including ASCO and SABCS-AACR. To learn more, visit .

诺维利娅得到了在医学大会上发表的经过同行评审的研究支持，包括ASCO和SABCS-AACR。欲了解更多信息，请访问 。

www.novellia.com

www.novellia.com

.

。

Media Contact:

媒体联系人：

SolComms

太阳通讯

[email protected]

电子邮件地址

SOURCE Novellia

来源 Novellia

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示